|
|
|
Insider
Information: |
Chase William J |
Relationship: |
Director |
City: |
North Chicago |
State: |
IL |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
222,715 |
|
Indirect Shares
|
501 |
|
|
Direct
Value |
$33,446,096 |
|
|
Indirect Value
|
$96,142 |
|
|
Total
Shares |
223,216 |
|
|
Total
Value |
$33,542,238 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Abbvie Inc. |
ABBV |
EVP, Finance & Adminis... |
2019-06-26 |
169,552 |
2019-06-26 |
501 |
Premium* |
|
Intellia Therapeutics, Inc. |
NTLA |
|
2024-06-12 |
26,693 |
2023-04-14 |
0 |
Premium* |
|
Grail, Llc |
GRAL |
Director |
2024-06-25 |
26,470 |
2024-06-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
34 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
NTLA |
Intellia Therapeutics, In... |
Director |
|
2023-04-14 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
6,800 |
|
% |
|
NTLA |
Intellia Therapeutics, In... |
Director |
|
2023-04-14 |
4 |
A |
$0.00 |
$0 |
D/D |
10,483 |
17,283 |
0 |
- |
|
NTLA |
Intellia Therapeutics, In... |
Director |
|
2023-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,673 |
18,956 |
0 |
- |
|
GRAL |
Grail, Llc |
Director |
|
2024-06-25 |
4 |
A |
$0.00 |
$0 |
D/D |
26,470 |
26,470 |
0 |
- |
|
NTLA |
Intellia Therapeutics, In... |
|
|
2024-06-12 |
4 |
A |
$0.00 |
$0 |
D/D |
7,737 |
26,693 |
0 |
- |
|
ABBV |
Abbvie Inc. |
EVP, Chief Financial Officer |
|
2013-02-07 |
4 |
D |
$37.14 |
$155,542 |
D/D |
(4,188) |
90,128 |
0 |
- |
|
ABBV |
Abbvie Inc. |
EVP, Chief Financial Officer |
|
2013-02-07 |
4 |
OE |
$32.00 |
$147,074 |
D/D |
4,567 |
94,316 |
0 |
- |
|
ABBV |
Abbvie Inc. |
EVP, Finance & Administration |
|
2018-12-12 |
4 |
S |
$90.00 |
$5,400,000 |
D/D |
(60,000) |
104,863 |
0 |
- |
|
ABBV |
Abbvie Inc. |
EVP, Chief Financial Officer |
|
2013-02-28 |
4 |
D |
$36.73 |
$193,200 |
D/D |
(5,260) |
138,656 |
0 |
- |
|
ABBV |
Abbvie Inc. |
EVP, Finance & Administration |
|
2019-02-28 |
4 |
D |
$79.41 |
$2,165,987 |
D/D |
(27,276) |
139,152 |
0 |
- |
|
ABBV |
Abbvie Inc. |
EVP, Chief Financial Officer |
|
2013-12-19 |
4 |
D |
$54.32 |
$334,014 |
D/D |
(6,149) |
140,119 |
0 |
- |
|
ABBV |
Abbvie Inc. |
EVP, Chief Financial Officer |
|
2013-02-19 |
4 |
D |
$37.58 |
$109,433 |
D/D |
(2,912) |
143,916 |
0 |
- |
|
ABBV |
Abbvie Inc. |
EVP, Chief Financial Officer |
|
2013-12-19 |
4 |
OE |
$28.97 |
$263,554 |
D/D |
7,612 |
146,268 |
0 |
- |
|
ABBV |
Abbvie Inc. |
EVP, Chief Financial Officer |
|
2013-02-14 |
4 |
A |
$0.00 |
$0 |
D/D |
56,700 |
146,828 |
0 |
- |
|
ABBV |
Abbvie Inc. |
EVP, Chief Financial Officer |
|
2018-02-28 |
4 |
S |
$119.44 |
$4,601,954 |
D/D |
(38,528) |
164,863 |
0 |
- |
|
ABBV |
Abbvie Inc. |
EVP, Chief Financial Officer |
|
2018-03-01 |
4 |
S |
$114.50 |
$3,709,687 |
D/D |
(32,400) |
164,863 |
0 |
- |
|
ABBV |
Abbvie Inc. |
EVP, Finance & Administration |
|
2019-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
61,565 |
166,428 |
0 |
- |
|
ABBV |
Abbvie Inc. |
EVP, Finance & Administration |
|
2019-06-26 |
4 |
B |
$67.30 |
$2,045,920 |
D/D |
30,400 |
169,552 |
2.74 |
- |
|
ABBV |
Abbvie Inc. |
EVP, Chief Financial Officer |
|
2016-02-29 |
4 |
D |
$56.00 |
$2,556,848 |
D/D |
(45,658) |
172,370 |
0 |
- |
|
ABBV |
Abbvie Inc. |
EVP, Chief Financial Officer |
|
2016-12-02 |
4 |
S |
$59.19 |
$390,654 |
D/D |
(6,600) |
172,370 |
0 |
- |
|
ABBV |
Abbvie Inc. |
EVP, Chief Financial Officer |
|
2016-12-02 |
4 |
OE |
$27.29 |
$180,114 |
D/D |
6,600 |
178,970 |
0 |
- |
|
ABBV |
Abbvie Inc. |
EVP, Chief Financial Officer |
|
2014-03-03 |
4 |
S |
$50.19 |
$198,259 |
D/D |
(3,948) |
180,068 |
0 |
- |
|
ABBV |
Abbvie Inc. |
EVP, Chief Financial Officer |
|
2014-12-22 |
4 |
S |
$68.00 |
$577,660 |
D/D |
(8,495) |
180,068 |
0 |
- |
|
ABBV |
Abbvie Inc. |
EVP, Chief Financial Officer |
|
2017-05-18 |
4 |
S |
$65.35 |
$2,502,905 |
D/D |
(38,300) |
183,543 |
0 |
- |
|
ABBV |
Abbvie Inc. |
EVP, Chief Financial Officer |
|
2014-02-28 |
4 |
D |
$51.91 |
$512,507 |
D/D |
(9,873) |
184,016 |
0 |
- |
|
34 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|